IP Library Granted Patent US 10,881,857
Granted Patent B2
US 10,881,857 · App. 16/183,456 · Granted Jan 5, 2021

Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods

Inventor: Jon Parker (San Jose, CA)
Assignee: Nevro Corp.
A61N1/36071A61N1/36125A61N1/36171A61N1/36175A61N1/3708
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,881,857
App. No.
16/183,456
Granted
Jan 5, 2021
Kind
B2
Abstract

Implanted pulse generators with reduced power consumption via signal strength-duration characteristics, and associated systems and methods are disclosed. A representative method for treating a patient in accordance with the disclosed technology includes receiving an input corresponding to an available voltage for an implanted medical device and identifying a signal delivery parameter value of an electrical signal based on a correlation between values of the signal delivery parameter and signal deliver amplitudes. The signal deliver parameter can include at least one of pulse width or duty cycle. The method can further include delivering an electrical therapy signal to the patient at the identified signal delivery parameter value using a voltage within a margin of the available voltage.

Claims (34)

1. A method for treating pain in a patient, comprising:

establishing a patient-specific correlation between amplitudes and pulse widths by identifying at least one pulse width/amplitude pair that produces a detectable result in the patient, wherein identifying the at least one pulse width/amplitude pair is based at least in part on (i) producing pain relief without producing paresthesia in the patient with a signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair, and/or (ii) producing an evoked potential in the patient with the signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair;

receiving at least one input corresponding to either a target therapy amplitude or a target therapy pulse width; and

updating the other of the target therapy amplitude or the target therapy pulse width according to the patient-specific correlation.

2. The method of claim 1 wherein identifying the at least one pulse width/amplitude pair is based at least in part on producing pain relief without producing paresthesia in the patient with the signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair.

3. The method of claim 1 wherein identifying the at least one pulse width/amplitude pair is based at least in part on producing an evoked potential in the patient with the signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair.

4. The method of claim 1 wherein establishing the patient-specific correlation includes using the at least one pulse width/amplitude pair to determine which of a plurality of pre-established pulse width/amplitude correlations applies to the patient.

5. The method of claim 4 wherein the at least one pulse width/amplitude pair is one of multiple pulse width/amplitude pairs used to determine which of the plurality of pre-established pulse width/amplitude correlations applies to the patient.

6. The method of claim 4 wherein establishing the pre-established pulse width/amplitude correlations includes using data from other patients.

7. The method of claim 1 wherein establishing the patient-specific correlation between amplitudes and pulse widths further comprises applying a correction factor to the at least one pulse width/amplitude pair that produces a detectable result in the patient.

8. The method of claim 7 wherein the correction factor is patient-specific.

9. A method for treating pain in a patient, comprising:

programming a pulse generator to:

establish a patient-specific correlation between amplitudes and pulse widths by identifying at least one pulse width/amplitude pair that produces a detectable result in the patient, wherein identifying the at least one pulse width/amplitude pair is based at least in part on (i) producing pain relief without producing paresthesia in the patient with a signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair, and/or (ii) producing an evoked potential in the patient with the signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair;

receive at least one input corresponding to either a target therapy amplitude or a target therapy pulse width; and

update the other of the target therapy amplitude or the target therapy pulse width according to the patient-specific correlation.

10. The method of claim 9 wherein identifying the at least one pulse width/amplitude pair is based at least in part on producing pain relief without producing paresthesia in the patient with the signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair.

11. The method of claim 9 wherein identifying the at least one pulse width/amplitude pair is based at least in part on producing an evoked potential in the patient with the signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair.

12. The method of claim 9 wherein establishing the patient-specific correlation includes using the at least one pulse width/amplitude pair to determine which of a plurality of pre-established pulse width/amplitude correlations applies to the patient.

13. The method of claim 12 wherein the at least one pulse width/amplitude pair is one of multiple pulse width/amplitude pairs used to determine which of the plurality of pre-established pulse width/amplitude correlations applies to the patient.

14. The method of claim 12 wherein establishing the pre-established pulse width/amplitude correlations includes using data from other patients.

15. The method of claim 9 wherein establishing the patient-specific correlation between amplitudes and pulse widths further comprises applying a correction factor to the at least one pulse width/amplitude pair that produces a detectable result in the patient.

16. The method of claim 15 wherein the correction factor is patient-specific.

17. A system for treating pain in a patient, comprising:

means for establishing a patient-specific correlation between amplitudes and pulse widths by identifying at least one pulse width/amplitude pair that produces a detectable result in the patient, wherein identifying the at least one pulse width/amplitude pair is based at least in part on (i) producing pain relief without producing paresthesia in the patient with a signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair, and/or (ii) producing an evoked potential in the patient with the signal having the pulse width and the amplitude of the at least one pulse width/amplitude pair;

means for receiving at least one input corresponding to either a target therapy amplitude or a target therapy pulse width; and

means for updating the other of the target therapy amplitude or the target therapy pulse width according to the patient-specific correlation.

18. The system of claim 17 wherein identifying the at least one pulse width/amplitude pair is based at least in part on producing pain relief without producing paresthesia in the patient with the signal having the pulse width and amplitude of the at least one pulse width/amplitude pair.

19. The system of claim 17 wherein identifying the at least one pulse width/amplitude pair is based at least in part on producing an evoked potential in the patient with the signal having the pulse width and amplitude of the at least one pulse width/amplitude pair.

20. The system of claim 17 wherein establishing the patient-specific correlation includes using the at least one pulse width/amplitude pair to determine which of a plurality of pre-established pulse width/amplitude correlations applies to the patient.

21. The system of claim 20 wherein the at least one pulse width/amplitude pair is one of multiple pulse width/amplitude pairs used to determine which of the plurality of pre-established pulse width/amplitude correlations applies to the patient.

22. The system of claim 20 wherein establishing the pre-established pulse width/amplitude correlations includes using data from other patients.

23. The system of claim 17 wherein establishing the patient-specific correlation between amplitudes and pulse widths further comprises applying a correction factor to the at least one pulse width/amplitude pair that produces a detectable result in the patient.

24. The system of claim 23 wherein the correction factor is patient-specific.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 053401 FRAME: 0780. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 7, 2020
From: PARKER, JON
To: NEVRO CORP.
Reel/Frame 054627/0463 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2020
From: PARKER, JON
To: NEVRO CORP.
Reel/Frame 053401/0780 →
Continuity (4)
Continuation 15227821 · Aug 3, 2016
Continuation 14710375 · May 12, 2015
Provisional Application 62000985 · May 20, 2014
Related Publication 20190269918A1 · Sep 5, 2019
Cited By (1)
US 12,440,676